James Crowley: The Complex Role of CRP in Cardiovascular Risk and Atherosclerosis
James Crowley, Professor of Medicine Emeritus at Brown University, Captain at U.S. Navy Reserve, shared a post on LinkedIn about a recent article by Paul M Ridker, published in Circulation, adding:
“Because CRP is an ‘acute-phase reactant’ and goes up during major trauma and infection, some physicians have long worried that CRP testing might be too nonspecific for clinical use.
However, multiple studies show that CRP, when measured appropriately with high-sensitivity assays in stable individuals, is quite specific for the prediction of future cardiovascular events.
In one recent study, elevated CRP levels were associated with an 8-fold increase in cardiovascular mortality, but had no predictive value for death from other causes.
Thus, a persistently elevated CRP level is indicative of the risk of heart disease and of the accelerated atherosclerosis that affects individuals with diabetes.
Thus it is surprising that a recently released large prospective study of a new medication that lowers CRP failed to lower the occurrence of CVD!
Similarly, results of the successful lowering of LPa, long suspected to cause inflammation in another large study also failed to lower CVD.
These surprising results of these studies have been reviewed by the prominent cardiologist Eric Topol who frequently has posted highly praised interviews with leading CVD researchers.”
Title: C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke
Author: Paul M Ridker

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?